ArticlePLoS genetics2025
A maize mutant in the glutamate receptor-like dwarf13 is modified by cis-acting natural variation and a cornichon homolog.
Article in PLoS genetics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Deciphering the molecular basis of complex traits requires understanding how natural genetic variation interacts with underlying biological pathways. In this study, we explored how natural genetic variation influences traits in maize affected by a semi-dominant maize dwarfing allele, Dwarf13-1 (D13-1) which encodes a defective ionotropic glutamate receptor (GLR). This allowed us to investigate natural genetic variation in the genome affecting GLR signaling in maize. We implemented an F1 association mapping (FOAM) approach, where heterozygous mutants carrying the semi-dominant D13-1 allele were crossed with a maize association panel. The resulting F1 families segregated 1:1 for mutant and wild-type phenotypes allowing comparisons between the congenic F1 hybrid siblings to identify and map natural alleles that interact with the D13-1 mutant allele. FOAM mapping detected two loci that modify the expression of the D13-1/+ mutant phenotype. The phenotypic impacts of both loci were epistatically controlled by D13-1, and only affected the phenotypes of mutant F1 hybrids. One, tropotriskaideka1 (tod1), encoded a maize homolog of the GLR-interacting cornichon gene and modified D13-1/+ mutant severity. A second, encoded by the d13 locus itself, affected the severity of the D13-1/+ phenotype via variation in the wild-type allele in the heterozygous mutants. By integrating gene expression analyses, these epistatic interactions, and SNP linkage information we identified multiple, unlinked, alleles affecting expression of the wild-type D13 transcript that modify mutant trait expression. Greater expression of the wild-type D13 allele increased plant height and suppressed D13-1/+ mutant severity, consistent with a multi-subunit complex GLR structure and complex-poisoning mode-of-action for the semi-dominant D13-1 allele. This approach identifies natural alleles affecting the GLR pathway in maize and establishes GLRs and their interactors as dose-dependent regulators of plant architecture. Our pathway-focused framework and epistasis testing of natural variants provides greater confidence in identifying genes contributing to complex traits.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.